General Biologicals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	243.34	251.65	217.12	262.18	308.77
Short-Term Investments	-	-	-	88.9	60
Trading Asset Securities	391.41	-	-	-	-
Cash & Short-Term Investments	634.75	251.65	217.12	351.08	368.77
Cash Growth	152.24%	15.90%	-38.16%	-4.80%	-22.13%
Accounts Receivable	68.8	96.69	84.36	57.18	42.31
Other Receivables	2.78	1.09	0.72	4.32	5.17
Receivables	71.58	97.78	85.09	61.5	47.49
Inventory	58.95	57.08	85.56	116.79	81.32
Prepaid Expenses	22.15	-	-	18.33	11.56
Other Current Assets	5.19	40.11	14.09	3.28	1.18
Total Current Assets	792.62	446.61	401.85	550.97	510.32
Property, Plant & Equipment	829.1	2,819	2,002	864.46	607.87
Long-Term Investments	409.07	40.45	38.16	36.68	38.52
Goodwill	-	21.61	20.68	20.68	20.68
Other Intangible Assets	52.12	32.71	36.19	41.09	44.58
Long-Term Deferred Tax Assets	-	-	-	11.93	18.91
Other Long-Term Assets	2,787	45.16	37.96	24.77	23.58
Total Assets	4,870	3,406	2,537	1,551	1,264
Accounts Payable	61.21	82.72	24.26	25.3	38.74
Accrued Expenses	-	15.11	18.51	12.2	12.95
Short-Term Debt	60	60	50	5	-
Current Portion of Long-Term Debt	-	41.04	1.59	1.57	3.24
Current Portion of Leases	8.6	107.67	117.73	10.1	7.75
Current Unearned Revenue	5.38	95.36	6.48	5.82	3.83
Other Current Liabilities	261.81	48.89	810.73	38.05	10.56
Total Current Liabilities	397	450.79	1,029	98.04	77.07
Long-Term Debt	1,966	1,697	33.54	0.13	1.71
Long-Term Leases	402.43	404.2	345.6	452.02	436.74
Long-Term Unearned Revenue	7.89	556.26	620.7	-	-
Pension & Post-Retirement Benefits	-	-	-	0.02	0.95
Long-Term Deferred Tax Liabilities	45.28	4.6	4.9	6.19	5.48
Other Long-Term Liabilities	1,178	6.65	6.65	301.11	7.84
Total Liabilities	3,997	3,119	2,041	857.51	529.79
Common Stock	708.25	608.25	598.25	598.25	598.25
Additional Paid-In Capital	122.85	99.28	87.8	87.8	87.8
Retained Earnings	36.95	-428.4	-207.03	-8.23	44.05
Comprehensive Income & Other	2.65	5.46	16.12	12.71	1.42
Total Common Equity	870.69	284.59	495.13	690.52	731.51
Minority Interest	1.78	1.9	1.51	2.55	3.14
Shareholders' Equity	872.47	286.48	496.65	693.07	734.66
Total Liabilities & Equity	4,870	3,406	2,537	1,551	1,264
Total Debt	2,437	2,310	548.46	468.82	449.44
Net Cash (Debt)	-1,803	-2,058	-331.34	-117.74	-80.66
Net Cash Per Share	-28.79	-34.40	-5.54	-1.97	-1.35
Filing Date Shares Outstanding	65.07	60.83	59.83	59.83	59.83
Total Common Shares Outstanding	65.07	60.83	59.83	59.83	59.83
Working Capital	395.62	-4.19	-627.45	452.94	433.25
Book Value Per Share	13.38	4.68	8.28	11.54	12.23
Tangible Book Value	818.57	230.26	438.27	628.76	666.26
Tangible Book Value Per Share	12.58	3.79	7.33	10.51	11.14
Buildings	-	50.02	50.02	49.85	49.86
Machinery	-	194.1	189.38	174.16	171.07
Construction In Progress	-	2,210	1,415	263.91	1.77
Leasehold Improvements	-	20.13	20.13	20.13	20.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.